Financhill
Back

Citius Oncology Inc. Stock Predictions

Citius Oncology Inc. Stock Forecast

  • Is Citius Oncology Inc. Stock Undervalued?
    The current Citius Oncology Inc. [CTOR] share price is $1.79. The Score for CTOR is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • CTOR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Citius Oncology Inc. Stock Go Up Next Year?

Data Unavailable

Citius Oncology Inc. Stock Rating

Data Unavailable

Citius Oncology Inc. Stock Price History

Is CTOR stock going to rise?

  • The current trend is moderately bullish and CTOR is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:

52-Week Data

52-Week High:
6.19
52-Week Low:
0.55

Prediction Charts

Market Cap:
128.1M
Price in USD:
1.79
Volume:
169.1K
Beta:
2.73

Technical Analysis

SMA50:
2.30
SMA100:
1.55
SMA200:
1.33
52-Wk Change:
-44.06%

Stock Predictions

  • Is Citius Oncology Inc. stock public?
    Yes, Citius Oncology Inc. is a publicly traded company.
  • What is the Citius Oncology Inc. stock quote today?
    The Citius Oncology Inc. stock price is 1.79 USD today.
  • How to buy Citius Oncology Inc. stock online?
    You can buy Citius Oncology Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jul-25 1.99 1.97 2.38 1.95
Jul-28 1.97 1.87 2.00 1.75
Jul-29 1.82 2.06 2.30 1.82
Jul-30 2.11 2.16 2.37 2.06
Jul-31 2.22 2.21 2.33 2.19
Aug-1 2.25 2.06 2.31 2.06
Aug-4 2.06 2.06 2.12 2.05
Aug-5 2.00 1.81 2.06 1.81
Aug-6 1.92 1.91 2.04 1.88
Aug-7 1.88 1.85 1.99 1.75
Aug-8 1.83 1.81 1.94 1.74
Aug-11 1.78 1.72 1.85 1.71
Aug-12 1.70 1.69 1.77 1.67
Aug-13 1.70 1.79 1.80 1.70

Citius Oncology Inc. Earnings

Data Unavailable

Citius Oncology Inc. Forecast Revenue Growth

Data Unavailable

* Citius Oncology Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.